Sponsored
ASAN's 1.7x P/S valuation faces risks from slow billings growth & churn. FRSH's 2.4x P/S shows strong ARR & margins.
Abbott faces $70M in damages over NEC claims. Over 1700 lawsuits loom, impacting its formula's valuation.
AVGO jumps 5.4%, lifting Nasdaq, while CRM dips 4.1%. Market shrugs off inflation & geopolitics.
WCC's EPS fell 5.9% yearly; WWD's EPS soared 29.4%. YOU's sales grew 21.2% with strong FCF.
IONQ's 99.99% fidelity leads quantum race. GOOG/MSFT invest heavily, eyeing crypto breaks. Upside potential high.
RNG's 4.5% sales growth & 1.3x P/S valuation raise flags. CAVA's 166x P/E & -12.8% EPS contraction signal risk.
ULH, NVRI, DHT show sales declines & negative cash flow. High debt & P/E ratios signal risk.
Sponsored
Must Read